Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Orange Biomed logo — A healthcare startup with cutting-edge diabetes management t...

Orange Biomed

A healthcare startup with cutting-edge diabetes management technology.

Founded 2021 United States Seattle, United States 13 employees Seed Total: $2.60B Health Care, Medical Devices

General Information

Company Name Orange Biomed
Founded Year 2021
Location United States Seattle, United States
Employees 13
Industries Health Care, Medical Devices
Funding Stage Seed
Business Model D2C, B2B, E Commerce
Revenue Model Product Sales, One Time Purchase
Social

BounceWatch is an independent company data service, not affiliated with Orange Biomed. To contact Orange Biomed, visit orangebiomed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orange Biomed compare?

A PDF of Orange Biomed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orange Biomed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Orange Biomed

Orange Biomed, a healthcare startup founded in 2021, is making strides in diabetes management technology with its cutting-edge innovations. Positioned within the Health Care and Medical Devices industries, the company operates out of the United States.

Currently, Orange Biomed is advancing its research on the OBM rapid A1c at Seoul Asan Medical Center, South Korea’s largest hospital. This strategic collaboration is significant, as the hospital is backed by the Hyundai group, a major South Korean conglomerate that emphasizes healthcare initiatives.

The company attracted a KRW1.00B seed round investment on January 10, 2023, led by Intops Investment. This financial backing underscores investor confidence in Orange Biomed's potential to innovate and lead in the sector of diabetes treatment and management.

Business keywords: Diabetes management, Medical devices, Microfluidic technology, Healthcare innovation, Biomedical research, Point-of-care testing, Home medical testing, Hyundai group, Seoul Asan Medical Center, Patient-centered care, Healthcare accessibility, Healthcare affordability

Services & Products

Rapid A1C testing
At-home diagnostic solutions
Clinical-quality medical devices
Healthcare provider support

Target Customers

Diabetic patients Healthcare providers Clinics and medical centers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round KRW1.00B 1
Intops Investment
Intops Investment
10 Jan 2023
Seed Round $2.60M -
29 Dec 2022
Seed Round KRW1.60B 2
Digital Healthcare Partners Seoul New Technology Investment Co.
Digital Healthcare Partners, Seoul New Technology Investment Co.
10 Aug 2022
Pre Seed Round $500.00K -
17 Dec 2021

Orange Biomed Alternatives & Competitors

View All Alternatives
Orange Biomed vs
DreaMed Diabetes
DreaMed Diabetes

Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plan...

Grant
AI, Biotechnology
Orange Biomed vs
Leuko
Leuko United States

Non-invasive white blood cell monitoring

Series A
11 employees
Biotechnology, Health Care
Orange Biomed vs
binx health
binx health United States

Creating new categories of healthcare solutions that put on-demand testing where people need it most...

Series F
86 employees
Health Care, Medical Devices
Compare Orange Biomed vs binx health
View all alternatives

FAQ About Orange Biomed

A healthcare startup with cutting-edge diabetes management technology.
Orange Biomed was founded in 2021.
Orange Biomed is headquartered in Seattle, United States.
Orange Biomed operates in Health Care and Medical Devices. Its work centres on Diabetes management, Medical devices, Microfluidic technology and Healthcare innovation. Its customers include Diabetic patients, Healthcare providers and Clinics and medical centers.
Orange Biomed has a D2C, B2B and E Commerce business model. Its revenue comes from Product Sales and One Time Purchase.
Orange Biomed has approximately 13 employees.
Orange Biomed has completed 4 funding rounds, raising a total of $2.60B. The latest funding stage is Seed.
Orange Biomed offers: Rapid A1C testing, At-home diagnostic solutions, Clinical-quality medical devices, Healthcare provider support.
Top alternatives and competitors to Orange Biomed include DreaMed Diabetes, Leuko, binx health, i-SENS, Inc. , MNCHIP. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orange Biomed and DreaMed Diabetes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orange Biomed, https://bouncewatch.com/company/orange-biomed, updated 21 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout